Literature DB >> 2503113

Passive smoking, salivary cotinine concentrations, and middle ear effusion in 7 year old children.

D P Strachan1, M J Jarvis, C Feyerabend.   

Abstract

OBJECTIVE: To assess the contribution of passive exposure to tobacco smoke to the development of middle ear underpressure and effusion.
DESIGN: Cross sectional observational study.
SETTING: One third of the primary schools in Edinburgh.
SUBJECTS: 892 Children aged 6 1/2 to 7 1/2 were examined, and satisfactory tympanograms were obtained in 872. Results of assay of salivary cotinine concentrations were available for 770 children, and satisfactory tympanograms were available for 736 of these. END POINT: Correlation of the prevalence of middle ear underpressure and effusion with concentrations of the marker of nicotine, cotinine, in the saliva of the children.
MEASUREMENTS AND MAIN RESULTS: Middle ear pressure and compliance were measured in both ears by impedance tympanometry. Salivary cotinine concentrations were assayed by gas-liquid chromatography. Cotinine concentrations increased with the number of smokers in the household. Girls had higher concentrations than boys, and children living in rented housing had higher concentrations than those living in housing owned by their parents. There was a trend towards more abnormal tympanometric findings with increasing cotinine concentration, the odds ratio for a doubling of the cotinine concentration being 1.14 (95% confidence interval 1.03 to 1.27). After adjustment for the sex of the child and housing tenure the odds ratio for a doubling of the cotinine concentration was 1.13 (1.00 to 1.28).
CONCLUSIONS: The results of this study are consistent with those of case-control studies of children attending for an operation to relieve middle ear effusion. They indicate that the disease should be added to the list of recognised hazards associated with passive smoking. About one third of the cases of middle ear effusion in this study were statistically attributable to exposure to tobacco smoke.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503113      PMCID: PMC1836817          DOI: 10.1136/bmj.298.6687.1549

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  23 in total

1.  Tympanometry and secretory otitis media. Observations on diagnosis, epidemiology, treatment, and prevention in prospective cohort studies of three-year-old children.

Authors:  M Fiellau-Nikolajsen
Journal:  Acta Otolaryngol Suppl       Date:  1983

2.  Epidemiology and middle ear effusion and tubal dysfunction. A one-year prospective study comprising monthly tympanometry in 387 non-selected 7-year-old children.

Authors:  J Lous; M Fiellau-Nikolajsen
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1981-12       Impact factor: 1.675

3.  The aetiology of glue ear--a case-control study.

Authors:  N Black
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1985-07       Impact factor: 1.675

4.  Geographical variations in use of surgery for glue ear.

Authors:  N Black
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

5.  Relevant and irrelevant predisposing factors in secretory otitis media.

Authors:  P B Van Cauwenberge
Journal:  Acta Otolaryngol Suppl       Date:  1984

6.  Middle ear disease assessed by impedance in primary school children in south London.

Authors:  S Portoian-Shuhaiber; T R Cullinan
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

7.  Surgery for glue ear--a modern epidemic.

Authors:  N Black
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

8.  Risk factors for persistent middle-ear effusions. Otitis media, catarrh, cigarette smoke exposure, and atopy.

Authors:  M J Kraemer; M A Richardson; N S Weiss; C T Furukawa; G G Shapiro; W E Pierson; C W Bierman
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

9.  Biochemical markers of smoke absorption and self reported exposure to passive smoking.

Authors:  M Jarvis; H Tunstall-Pedoe; C Feyerabend; C Vesey; Y Salloojee
Journal:  J Epidemiol Community Health       Date:  1984-12       Impact factor: 3.710

10.  Validation of an automatic otoadmittance middle ear analyzer.

Authors:  T J Fria; E I Cantekin; G Probst
Journal:  Ann Otol Rhinol Laryngol       Date:  1980 May-Jun       Impact factor: 1.547

View more
  24 in total

1.  Passive smoking and otitis media with effusion.

Authors:  G Barr
Journal:  BMJ       Date:  1992-02-08

2.  Passive smoking and otitis media with effusion.

Authors:  A Hinton
Journal:  BMJ       Date:  1992-01-04

3.  Metabolic Consequences of Concomitant Strongyloides stercoralis Infection in Patients With Type 2 Diabetes Mellitus.

Authors:  Anuradha Rajamanickam; Saravanan Munisankar; Yukthi Bhootra; Chandrakumar Dolla; Kannan Thiruvengadam; Thomas B Nutman; Subash Babu
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

4.  Passive smoking and otitis media with effusion.

Authors:  G S Barr; A P Coatesworth
Journal:  BMJ       Date:  1991-10-26

5.  Passive smoking and health: should we believe Philip Morris's "experts"?

Authors:  G D Smith; A N Phillips
Journal:  BMJ       Date:  1996-10-12

Review 6.  Poverty and the health of children and adolescents.

Authors:  R Reading
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

7.  Serum cotinine levels should optimally be measured when evaluating the outcomes of cartilage tympanoplasty in smokers.

Authors:  Xudan Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-04       Impact factor: 2.503

8.  Passive smoking and middle ear effusion in children.

Authors: 
Journal:  BMJ       Date:  1989-07-22

9.  Selecting persistent glue ear for referral in general practice: a risk factor approach.

Authors: 
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

10.  Changes in child exposure to secondhand smoke after implementation of smoke-free legislation in Wales: a repeated cross-sectional study.

Authors:  Jo C Holliday; Graham F Moore; Laurence A R Moore
Journal:  BMC Public Health       Date:  2009-11-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.